Skip to content

Third Eye Retroscope Randomized Clinical Evaluation

Third Eye Retroscope Randomized Clinical Evaluation - The *TERRACE* Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33766
Enrollment
80
Registered
2009-02-24
Start date
2009-03-09
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adenomata polyps

Interventions

The Avantis Third Eye Retroscope auxiliary imaging system includes a catheter, a cap and a video processor system. The cap is placed on the tip of colonoscope prior to initiation of the procedure. T

Sponsors

Avantis medical systems. Inc
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. The patient is undergoing colonoscopy for screening, for surveillance in follow-up of previous polypectomy or for diagnostic workup. 2. Age >= 18 years. 3. The patient must understand and provide written consent for the procedure.

Exclusion criteria

Exclusion criteria: 1. Age under 18. 2. Patients with a history of colonic resection. 3. Patients with inflammatory bowel disease. 4. Patients with a personal history of polyposis syndrome. 5. Patients with suspected chronic stricture potentially precluding complete colonoscopy. 6. Patients with diverticulitis or toxic megacolon. 7. Patients with a history of radiation therapy to abdomen or pelvis. 8. Patients who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the patient*s participation in this study. 9. No written informed consent.

Design outcomes

Primary

MeasureTime frame
1. Study the overall miss rate of polyps detected with the third eye retroscope compared to standard colonoscopy. 2. Study the overall miss rate of adenoma detected with the third eye retroscope compared to standard colonoscopy.

Secondary

MeasureTime frame
1. Study polyp characteristics, including the histological and pathological, of each for both groups. 2. Analyze the time observations, including time to cecum, time for withdrawal, the withdrawal time for both groups and total procedural times for each colonoscopy procedure.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)